DOV KADMON to Histocompatibility Antigens Class II
This is a "connection" page, showing publications DOV KADMON has written about Histocompatibility Antigens Class II.
Connection Strength
0.024
-
HLA-restricted NY-ESO-1 peptide immunotherapy for metastatic castration resistant prostate cancer. Invest New Drugs. 2014 Apr; 32(2):235-242.
Score: 0.024
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.